DAFNA Capital Management LLC - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 1 filers reported holding AKARI THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q2 2016$6,000
-90.9%
458
-90.3%
0.01%
-91.2%
Q1 2016$66,000
-45.5%
4,741
-43.2%
0.06%
-47.2%
Q4 2015$121,000
-80.9%
8,341
-68.4%
0.11%
-82.8%
Q3 2015$633,00026,3900.63%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 178,091$703,4590.52%
View complete list of AKARI THERAPEUTICS PLC shareholders